Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Pharmacology Research & Perspectives|August 1, 2024
Integrase inhibitor drugs during pregnancy and congenital anomalies: A case/non-case study from the global pharmacovigilance database VigiBase®Laura Saint-Lary, Isabelle Lacroix, Valériane Leroy, et al.Canadian Journal on Aging = La Revue Canadienne Du Vieillissement|December 27, 2024
[Coconstruire autrement avec des personnes aînées grâce à la science-fiction: nouveaux regards sur la recherche en robotique d'assistance sociale]Isabelle Lacroix, Mélanie Levasseur, François Michaud, et al.The Journal of Biological Chemistry|January 10, 2002
Sp1 transcriptional activity is up-regulated by phosphatase 2A in dividing T lymphocytesIsabelle Lacroix, Carol Lipcey, Jean Imbert, et al.Pharmacoepidemiology and Drug Safety|March 26, 2025
Tramadol During Pregnancy: Risk of Adverse Pregnancy Outcome and Major Congenital Anomalies. A Comparative Study in the EFEMERIS DatabaseEva Ferrer, Laurane Delteil, Anthony Caillet, et al.Therapie|November 20, 2016
[Women's knowledge of folic acid]Mathilde Salgues, Christine Damase-Michel, Jean-Louis Montastruc, et al.Urology Case Reports|September 13, 2016
Heterophile Antibody Interference led to Unneeded Chemotherapy in a Testicular Cancer PatientDaniele G Soares, Françoise Millot, Isabelle Lacroix, et al.Therapie|January 22, 2008
[Adverse drug reactions in pregnant women]Isabelle Lacroix, Cendrine Cabou, Jean-Louis Montastruc, et al.Therapie|November 10, 2021
Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss - An observational study using the EFEMERIS databaseClémentine Vabre, Mélanie Araujo, Christine Damase-Michel, et al.Pharmacy Practice|August 30, 2014
Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees areaChristine Damase-Michel, Juliette Pichereau, Atul Pathak, et al.Pageof 7